[1] 中华人民共和国药典:四部[S].2020:21-22.
[2] Ruby PK,Pathak SM,Aggarwal D.Critical Attributes ofTransdermal Drug Delivery System(TDDS)--a GenericProduct Development Review[J].Drug Dev Ind Pharm,2014,40(11):1421-1428.
[3] Marwah H,Garg T,Goyal AK,et al.PermeationEnhancer Strategies in Transdermal Drug Delivery[J].DrugDeliv,2016,23(2):564-578.
[4] Barry BW.Novel Mechanisms and Devices to EnableSuccessful Transdermal Drug Delivery[J].Eur J PharmSci,2001,14(2):101-114.
[5] Lee J,Kwon K,Kim M,et al.Transdermal IontophoresisPatch with Reverse Electrodialysis[J].Drug Deliv,2017,24(1):701-706.
[6] 赵雪玮,张楠,刘成禹,等.经皮给药系统中透皮促渗透的研究概况[J].中国社区医师,2020,36(10):9,11.
[7] Vaidya J,Shende P.Potential of Sonophoresis asa Skin Penetration Technique in the Treatment ofRheumatoid Arthritis with Transdermal Patch[J].AAPSPharmSciTech,2020,21(5):180.
[8] 董王明,江昌照,叶金翠,等.经皮给药制剂促透方法研究进展[J].中国新药杂志,2020,29(18):2089-2097.
[9] Lane ME.Skin Penetration Enhancers[J].Int J Pharm,2013,447(1-2):12-21.
[10] Nasr M,Younes H,Abdel-Rashid RS.Formulationand Evaluation of Cubosomes Containing Colchicine forTransdermal Delivery[J].Drug Deliv Transl Res,2020,10(5):1302-1313.
[11] 曾令军,张灵娜,陈旭,等.立方液晶载体在经皮给药系统中的促渗机制研究[J].中国药师,2021,24(9):1670-1675.
[12] Salah S,Mahmoud AA,Kamel AO.Etodolac TransdermalCubosomes for the Treatment of Theumatoid Arthritis:ex Vivo Permeation and in Vivo PharmacokineticStudies[J].Drug Deliv,2017,24(1):846-856.
[13] Mohyeldin SM,Mehanna MM,Elgindy NA.Superiorityof Liquid Crystalline Cubic Nanocarriers as HormonalTransdermal Vehicle:Comparative Human SkinPermeation-supported Evidence[J].Expert Opin DrugDeliv,2016,13(8):1049-1064.
[14] Hasan M,Khatun A,Fukuta T,et al.Noninvasive Transdermal Delivery of Liposomes by Weak ElectricCurrent[J].Adv Drug Deliv Rev,2020,154-155:227-235.
[15] Salimi A,Gobadian H,Sharif Makhmalzadeh B.DermalPharmacokinetics of Rivastigmine-loaded Liposomes:an ex Vivo-in vivo Correlation Study[J].J Liposome Res,2021,31(3):246-254.[1 6] A b d E l-A l i m S H,K a s s e m A A,B a s h a M,e tal.Comparative Study of Liposomes,Ethosomesand Transfersomes as Carriers for Enhancing theEransdermal Delivery of Diflunisal:In Vitro and in VivoEvaluation[J].Int J Pharm,2019,563:293-303.
[17] Lopez-Ramirez MA,Soto F,Wang C,et al.Built-inActive Microneedle Patch with Enhanced Autonomous DrugDelivery[J].Adv Mater,2020,32(1):e1905740.
[18] Lopez-Ramirez MA,Kupor D,Marchiori L,et al.Combinatorial Microneedle Patch with Tunable ReleaseKinetics and Dual Fast-Deep/Sustained ReleaseCapabilities[J].J Mater Chem B,2021,9(9):2189-2199.
[19] 巫传玲.微针技术在经皮和其他组织器官给药领域的研究进展[J].中国医药工业杂志,2018,49(9):1221-1229.
[20] Holmgaard R,Benfeldt E,Nielsen JB.PercutaneousPenetration——methodological Considerations[J].BasicClin Pharmacol Toxicol,2014,115(1):101-109.
[21] 侯巍,于海,焦淑清,等.两种扩散池在透皮实验中的应用[J].黑龙江医药科学,2002(5):66.
[22] Córdoba-Díaz M,Nova M,Elorza B,et al.ValidationProtocol of an Automated in-line Flow-through DiffusionEquipment for in Vitro Permeation Studies[J].J ControlRelease,2000,69(3):357-367.
[23] Pulsoni I,Lubda M,Aiello M,et al.Comparison BetweenFranz Diffusion Cell and a Novel Micro-physiologicalSystem for in Vitro Penetration Assay Using Different SkinModels [J].SLAS Technol,2022,27(3):161-171.
[24] Abd E,Yousef SA,Pastore MN,et al.Skin Models forthe Testing of Transdermal Drugs[J].Clin Pharmacol,2016,8:163-176.
[25] Santos LL,Swofford NJ,Santiago BG.In Vitro PermeationTest(IVPT)for Pharmacokinetic Assessment of TopicalDermatological Formulations[J].Curr Protoc Pharmacol,2020,91(1):e79.
[26] Zhang D,Bian Q,Zhou Y,et al.The Application ofLabel-free Imaging Technologies in Transdermal Researchfor Deeper Mechanism Revealing[J].Asian J Pharm Sci,2021,16(3):265-279.[2 7] C a n u t o H C,F i s h b e i n K W,H u a n g A,e t a l.Characterization of Skin Abnormalities in a Mouse Model ofOsteogenesis Imperfecta Using High Resolution MagneticResonance Imaging and Fourier Transform Infrared ImagingSpectroscopy[J].NMR Biomed,2012,25(1):169-176.
[28] Sreedhar H,Varma VK,Nguyen PL,et al.Highdefinition Fourier Transform Infrared(FT-IR)Spectroscopic Imaging of Human Tissue Sections TowardsImproving Pathology[J].J Vis Exp,2015(95):52332.
[29] Andanson JM,Chan KL,Kazarian SG.High-throughputSpectroscopic Imaging Applied to Permeation Through theSkin[J].Appl Spectrosc,2009,63(5):512-517.
[30] Kong R,Bhargava R.Characterization of Porcine Skin as aModel for Human Skin Studies Using Infrared SpectroscopicImaging[J].Analyst,2011,136(11):2359-2366.
[31] Egawa M.Raman Microscopy for Skin Evaluation[J].Analyst,2021,146(4):1142-1150.
[32] Ramya AN,Arya JS,Madhukrishnan M,et al.RamanImaging:An Impending Approach Towards CancerDiagnosis[J].Chem Asian J,2021,16(5):409-422.
[33] Petersen M,Yu Z,Lu X.Application of Raman SpectroscopicMethods in Food Safety:A Review[J].Biosensors(Basel),2021,11(6):187.
[34] Jones RR,Hooper DC,Zhang L,et al.RamanTechniques:Fundamentals and Frontiers[J].Nanoscale ResLett,2019,14(1):231.
[35] Ito T,Iguchi R,Matsuoka F,et al.Label-freeSkin Penetration Analysis Using Time-resolved,Phase-modulated Stimulated Raman ScatteringMicroscopy[J].Biomed Opt Express,2021,12(10):6545-6557.
[36] Buchberger AR,DeLaney K,Johnson J,et al.Mass Spectrometry Imaging:A Review of EmergingAdvancements and Future Insights[J].Anal Chem,2018,90(1):240-265.
[37] Russo C,Brickelbank N,Duckett C,et al.Quantitative Investigation of Terbinafine Hydrochloride Absorption intoa Living Skin Equivalent Model by MALDI-MSI[J].AnalChem,2018,90(16):10031-10038.
[38] Schulz S,Becker M,Groseclose MR,et al.AdvancedMALDI Mass Spectrometry Imaging in PharmaceuticalResearch and Drug Development[J].Curr OpinBiotechnol,2019,55:51-59.
[39] Handler AM,Fallah M,Just Pedersen A,et al.MALDIMass Spectrometry Imaging as a Complementary AnalyticalMethod for Improved Skin Distribution Analysis of DrugMolecule and Excipients[J].Int J Pharm,2020,590:119949.
[40] Handler AM,Pommergaard Pedersen G,TroensegaardNielsen K,et al.Quantitative MALDI Mass SpectrometryImaging for Exploring Cutaneous Drug Delivery ofTofacitinib in Human Skin[J].Eur J Pharm Biopharm,2021,159:1-10.
